Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.49B | $4.43B | $4.89B | $4.88B | $5.54B | $5.80B | $5.20B | $5.06B | $4.99B | $5.04B |
| Revenue growth | — | -1.4% | 10.5% | -0.3% | 13.6% | 4.7% | -10.3% | -2.7% | -1.4% | 0.9% |
| Gross profit | $3.63B | $3.58B | $3.97B | $3.92B | $4.39B | $4.56B | $4.03B | $3.87B | $3.89B | $3.92B |
| Gross margin | 81.0% | 80.8% | 81.2% | 80.4% | 79.2% | 78.6% | 77.4% | 76.5% | 77.9% | 77.9% |
| Operating income | $458M | $617M | $683M | $568M | $641M | $734M | $545M | $356M | $386M | $481M |
| Operating margin | 10.2% | 13.9% | 14.0% | 11.6% | 11.6% | 12.7% | 10.5% | 7.0% | 7.7% | 9.5% |
| Net income | $260M | $214M | $297M | $311M | $373M | $447M | $321M | $142M | $254M | $228M |
| Net margin | 5.8% | 4.8% | 6.1% | 6.4% | 6.7% | 7.7% | 6.2% | 2.8% | 5.1% | 4.5% |
| EPS (diluted) | $1.51 | $1.29 | $1.98 | $2.20 | $2.77 | $4.13 | $3.23 | $1.42 | $2.50 | $2.20 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $367M | $591M | $648M | $458M | $629M | $460M | $353M | $358M | $285M | $333M |
| Capital expenditures | $143M | $95.5M | $84.0M | $106M | $112M | $151M | $156M | $135M | $122M | $80.4M |
| Free cash flow | $224M | $495M | $564M | $351M | $517M | $309M | $196M | $223M | $163M | $253M |
| Share buybacks | $13.2M | $844M | $750M | $16.7M | $924M | $1.01B | $147M | $11.0M | $8.30M | $8.20M |
| Dividends paid | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $844M | $1.28B | $1.20B | $839M | $1.05B | $602M | $508M | $575M | $415M | $353M |
| Total assets | $2.57B | $2.90B | $2.79B | $2.68B | $3.08B | $2.82B | $2.73B | $2.81B | $2.73B | $2.79B |
| Total liabilities | $2.37B | $3.23B | $3.51B | $3.07B | $3.93B | $4.21B | $4.00B | $3.87B | $3.53B | $3.30B |
| Long-term debt | $1.44B | $2.17B | $1.77B | $1.78B | $2.41B | $2.73B | $2.66B | $2.25B | $1.98B | $1.97B |
| Shareholders' equity | $196M | -$335M | -$723M | -$390M | -$856M | -$1.39B | -$1.27B | -$1.06B | -$801M | -$515M |
| Retained earnings | -$66.3M | -$248M | -$526M | -$215M | -$687M | -$1.17B | -$1.20B | -$1.06B | -$808M | -$580M |
| Shares (wtd avg diluted) | 172M | 166M | 150M | 142M | 135M | 108M | 99.5M | 100M | 102M | 104M |
Every figure is extracted from HERBALIFE LTD.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.